tocilizumab,venetoclax
abbvie,roche
['toci', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders),(-dreamlike)', 'venetoclax']
really nice analysis by alex bazinet demonstrating that achieving mrd negative cr matters more than how you get there: mainly for eln int and adv risk aml - with intense or low-int rx. #ash22 
Tapan Kadia, MD _x000D_
- Leukemia Doc at MD Anderson Cancer Center _x000D_
 Leukemia, clinical/translational research.  Views, posts and opinions shared are my own.